Literature DB >> 17603765

Questionnaire on neuropathic pain: a European neurologist survey.

C Sommer1, C Geis, M Haanpää, J Serra, E Tan, G Cruccu.   

Abstract

A survey was conducted among European neurologists to obtain information on their interest in, knowledge on, and practice in the treatment of neuropathic pain. A simple questionnaire with 11 closed and one open question was distributed at national meetings, via e-mail lists of national Neurological Societies, and through the EFNS website. Data were collected from 745 neurologists in 11 countries. The majority of the respondents stated to be familiar with neuropathic pain and considered it part of their specialty. The ratio between peripheral and central neuropathic pains was 10:1, with diabetic neuropathy and radiculopathy the conditions being seen most often. Antiepileptic and antidepressant drugs were by far the drug classes most used (73%), with 2/3 of the patients reaching at least moderate pain relief.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603765     DOI: 10.1007/s10072-007-0806-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  7 in total

1.  Recommendations for using opioids in chronic non-cancer pain.

Authors:  Eija Kalso; Laurie Allan; Paul L I Dellemijn; Clara C Faura; Wilfried K Ilias; Troels S Jensen; Serge Perrot; Leon H Plaghki; Michael Zenz
Journal:  Eur J Pain       Date:  2003       Impact factor: 3.931

Review 2.  Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.

Authors:  Elon Eisenberg; Ewan D McNicol; Daniel B Carr
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

Review 3.  Algorithm for neuropathic pain treatment: an evidence based proposal.

Authors:  N B Finnerup; M Otto; H J McQuay; T S Jensen; S H Sindrup
Journal:  Pain       Date:  2005-10-06       Impact factor: 6.961

4.  EFNS guidelines on pharmacological treatment of neuropathic pain.

Authors:  N Attal; G Cruccu; M Haanpää; P Hansson; T S Jensen; T Nurmikko; C Sampaio; S Sindrup; P Wiffen
Journal:  Eur J Neurol       Date:  2006-11       Impact factor: 6.089

5.  Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study.

Authors:  A Devers; B S Galer
Journal:  Clin J Pain       Date:  2000-09       Impact factor: 3.442

6.  Diagnosis and treatment of neuropathic pain.

Authors:  Mark S Wallace
Journal:  Curr Opin Anaesthesiol       Date:  2005-10       Impact factor: 2.706

7.  EFNS guidelines on neuropathic pain assessment.

Authors:  G Cruccu; P Anand; N Attal; L Garcia-Larrea; M Haanpää; E Jørum; J Serra; T S Jensen
Journal:  Eur J Neurol       Date:  2004-03       Impact factor: 6.089

  7 in total
  1 in total

1.  To become a pain specialist one has to understand the nervous system, yet the specialists of the nervous system still have a long way to go before understanding pain.

Authors:  P Marchettini; C Solaro
Journal:  Neurol Sci       Date:  2007-08       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.